CBAN, US19623P1012

CBAN stock heads toward a merger vote after approval clears

Published on 10/07/2026 at 06:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CBAN stock faces an October 14, 2026 shareholder vote after merger approvals arrived on September 17, 2026. Q2 net income reached USD 10.857 million.

CBAN, US19623P1012, Illustration mit AI erstellt.
CBAN, US19623P1012, Illustration mit AI erstellt.

CBAN stock was last at USD 20.43 on the NYSE on October 6, 2026 at 4:00 p.m. ET, up USD 0.02, or 0.10 percent, from the prior session. The immediate company catalyst is Colony Bankcorp's planned combination with First Reliance Bancshares, which cleared regulatory approvals on September 17, 2026.

Merger reaches shareholder vote

According to Business Wire on September 17, 2026, Colony Bankcorp and First Reliance obtained all regulatory approvals for the proposed merger. Shareholders of both companies are scheduled to vote on October 14, 2026, while the transaction targets a November 1, 2026 closing.

The deal is valued at USD 163 million. The combined company is projected to have USD 5 billion in assets, USD 4 billion in deposits and USD 3.2 billion in loans, giving the transaction a scale that is materially larger than Colony's standalone USD 3.6 billion asset base at June 30, 2026.

Q2 earnings add operating support

Colony's second-quarter 2026 net income reached USD 10.857 million, compared with USD 8.204 million in the first quarter, a 32.3 percent increase. Diluted earnings per share rose to USD 0.51 from USD 0.39 over the same periods, while net interest income increased to USD 29.869 million from USD 29.203 million.

Business Wire reports that second-quarter 2026 net income was USD 10.9 million, or USD 0.51 per diluted share, versus USD 8.2 million and USD 0.39 per share in the first quarter. The figures give the merger story an earnings backdrop, although the vote and integration process remain the next concrete milestones.

Consensus target exceeds market price

According to MarketBeat on September 26, 2026, the consensus rating was Moderate Buy, based on four analysts, with a USD 23.00 target. That target stands 12.6 percent above the October 6 price of USD 20.43, while the same report listed a Wall Street Zen upgrade from Hold to Buy.

The market still prices CBAN below its 52-week high of USD 22.46, while the low stands at USD 15.80. The USD 20.43 price and USD 432.3 million market capitalization leave the shareholder vote as the next measurable test for whether the merger plan can narrow that valuation gap.

CBAN stock holds below yearly high

CBAN was last at USD 20.43 on the NYSE on October 6, 2026 at 4:00 p.m. ET, with 110,035 shares traded and a 52-week range of USD 15.80 to USD 22.46.

CBAN stock facts

  • Company: Colony Bankcorp, Inc.
  • ISIN: US19623P1012
  • Ticker: CBAN
  • Trading venue: NYSE
  • Price (as of October 6, 2026, 4:00 p.m. ET): USD 20.43
  • Market capitalization: USD 432.3 million (as of October 6, 2026)
  • 52-week range: USD 15.80-22.46 (as of October 6, 2026)
  • Sector / Industry: Financial Services / Regional Banks

Upcoming dates for CBAN stock

  • October 14, 2026: Shareholder vote on the First Reliance merger
  • November 1, 2026: Targeted merger closing

More news and analyses on CBAN stock

Disclaimer...

en | US19623P1012 | CBAN | boerse | 70250204 | bgmi